Chhillar B, Sodhi N, Kadian R, Neres E, Yadav M, Kundu M
ACS Omega. 2025; 10(7):6396-6405.
PMID: 40028082
PMC: 11865972.
DOI: 10.1021/acsomega.4c05366.
Zhao Y, Mei Y, Liu Z, Sun J, Tian Y
Nat Commun. 2025; 16(1):1848.
PMID: 39984456
PMC: 11845772.
DOI: 10.1038/s41467-025-57100-5.
Yoo J, Lee J, Ahn B, Han J, Lim M
Chem Sci. 2025; 16(5):2105-2135.
PMID: 39810997
PMC: 11726323.
DOI: 10.1039/d4sc06762b.
Xie J, Su Y, Shang W, Wu Y, He J, Li T
Apoptosis. 2024; 30(1-2):488-505.
PMID: 39702813
DOI: 10.1007/s10495-024-02059-9.
Krasnovskaya O, Abramchuk D, Vaneev A, Gorelkin P, Abakumov M, Timoshenko R
ACS Omega. 2024; 9(43):43376-43384.
PMID: 39493999
PMC: 11525521.
DOI: 10.1021/acsomega.4c03152.
Functional Nanomaterials for the Diagnosis of Alzheimer's Disease: Recent Progress and Future Perspectives.
Al Abdullah S, Najm L, Ladouceur L, Ebrahimi F, Shakeri A, Al-Jabouri N
Adv Funct Mater. 2024; 33(37).
PMID: 39309539
PMC: 11415277.
DOI: 10.1002/adfm.202302673.
Alzheimer's disease: a review on the current trends of the effective diagnosis and therapeutics.
Abdul Manap A, Almadodi R, Sultana S, Sebastian M, Kavani K, Lyenouq V
Front Aging Neurosci. 2024; 16:1429211.
PMID: 39185459
PMC: 11341404.
DOI: 10.3389/fnagi.2024.1429211.
An N-terminal acidic β-sheet domain is responsible for the metal-accumulation properties of amyloid-β protofibrils: a molecular dynamics study.
Gomez-Castro C, Quintanar L, Vela A
J Biol Inorg Chem. 2024; 29(4):407-425.
PMID: 38811408
PMC: 11186886.
DOI: 10.1007/s00775-024-02061-1.
Neuromodulation by nanozymes and ultrasound during Alzheimer's disease management.
Karthika V, Sridharan B, Nam J, Kim D, Lim H
J Nanobiotechnology. 2024; 22(1):139.
PMID: 38555420
PMC: 10981335.
DOI: 10.1186/s12951-024-02406-7.
Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer's disease.
Zhou C, Zeng F, Yang H, Liang Z, Xu G, Li X
Eur J Nucl Med Mol Imaging. 2024; 51(10):2953-2969.
PMID: 38502215
DOI: 10.1007/s00259-024-06690-1.
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease.
Pyka P, Haberek W, Wiecek M, Szymanska E, Ali W, Cios A
J Med Chem. 2024; 67(2):1580-1610.
PMID: 38190615
PMC: 10823479.
DOI: 10.1021/acs.jmedchem.3c02148.
Recent progress of small-molecule-based theranostic agents in Alzheimer's disease.
Gao F, Chen J, Zhou Y, Cheng L, Hu M, Wang X
RSC Med Chem. 2023; 14(11):2231-2245.
PMID: 37974955
PMC: 10650505.
DOI: 10.1039/d3md00330b.
A Fenton Approach to Aromatic Radical Cations and Diarylmethane Synthesis.
Iii R, Lujan B, Martinez A, Manasi R, DeBow J, Kou K
J Org Chem. 2023; 88(21):15060-15066.
PMID: 37847050
PMC: 10629232.
DOI: 10.1021/acs.joc.3c01505.
Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.
Abelein A
Acc Chem Res. 2023; 56(19):2653-2663.
PMID: 37733746
PMC: 10552549.
DOI: 10.1021/acs.accounts.3c00370.
Designing multi-target-directed flavonoids: a strategic approach to Alzheimer's disease.
Park S, Kim M, Lin Y, Hong M, Nam G, Mieczkowski A
Chem Sci. 2023; 14(35):9293-9305.
PMID: 37712013
PMC: 10498667.
DOI: 10.1039/d3sc00752a.
Transition metal ions and neurotransmitters: coordination chemistry and implications for neurodegeneration.
Yoo J, Han J, Lim M
RSC Chem Biol. 2023; 4(8):548-563.
PMID: 37547459
PMC: 10398360.
DOI: 10.1039/d3cb00052d.
Modified Tacrine Derivatives as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Synthesis, Biological Evaluation, and Molecular Modeling Study.
Fares S, El Husseiny W, Selim K, Massoud M
ACS Omega. 2023; 8(29):26012-26034.
PMID: 37521639
PMC: 10373466.
DOI: 10.1021/acsomega.3c02051.
Biological Oxidations and Nitrations Promoted by the Hemin-Aβ Complex.
De Caro S, De Soricellis G, DellAcqua S, Monzani E, Nicolis S
Antioxidants (Basel). 2023; 12(7).
PMID: 37507859
PMC: 10376006.
DOI: 10.3390/antiox12071319.
An AIE-Active NIR Fluorescent Probe with Good Water Solubility for the Detection of Aβ Aggregates in Alzheimer's Disease.
Ji Y, Hou M, Zhou W, Ning Z, Zhang Y, Xing G
Molecules. 2023; 28(13).
PMID: 37446772
PMC: 10343367.
DOI: 10.3390/molecules28135110.
Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine.
Botchway B, Liu X, Zhou Y, Fang M
J Transl Med. 2023; 21(1):351.
PMID: 37244993
PMC: 10224607.
DOI: 10.1186/s12967-023-04220-5.
